103 related articles for article (PubMed ID: 16858958)
1. Oxcarbazepine as add-on therapy in Thai epileptic patients with refractory partial seizures.
Kraiprab P; Chinvarun Y; Tantisira MH
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S193-201. PubMed ID: 16858958
[TBL] [Abstract][Full Text] [Related]
2. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.
Barcs G; Walker EB; Elger CE; Scaramelli A; Stefan H; Sturm Y; Moore A; Flesch G; Kramer L; D'Souza J
Epilepsia; 2000 Dec; 41(12):1597-607. PubMed ID: 11114219
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
4. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.
Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D
Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial.
French JA; Baroldi P; Brittain ST; Johnson JK;
Acta Neurol Scand; 2014 Mar; 129(3):143-53. PubMed ID: 24359313
[TBL] [Abstract][Full Text] [Related]
8. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
Pauletto G; Bergonzi P;
Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
[TBL] [Abstract][Full Text] [Related]
9. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
Piña-Garza JE; Espinoza R; Nordli D; Bennett DA; Spirito S; Stites TE; Tang D; Sturm Y
Neurology; 2005 Nov; 65(9):1370-5. PubMed ID: 16275822
[TBL] [Abstract][Full Text] [Related]
10. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy.
Beydoun A; Sachdeo RC; Kutluay E; McCague K; D'Souza J
Epilepsia; 2003 Sep; 44(9):1160-5. PubMed ID: 12919387
[TBL] [Abstract][Full Text] [Related]
11. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
[TBL] [Abstract][Full Text] [Related]
13. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.
Christe W; Krämer G; Vigonius U; Pohlmann H; Steinhoff BJ; Brodie MJ; Moore A
Epilepsy Res; 1997 Mar; 26(3):451-60. PubMed ID: 9127726
[TBL] [Abstract][Full Text] [Related]
14. Oxcarbazepine therapy in very young children: a single-center clinical experience.
Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy.
Dogan EA; Usta BE; Bilgen R; Senol Y; Aktekin B
Epilepsy Behav; 2008 Jul; 13(1):156-61. PubMed ID: 18331816
[TBL] [Abstract][Full Text] [Related]
16. Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg/day) in a B.I.D. regimen.
Jones MW; Blume WT; Guberman A; Lee MA; Pillay N; Weaver DF; Veloso F; Holdich TA
Seizure; 2002 Mar; 11(2):104-13. PubMed ID: 11945097
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine extended-release as adjunctive therapy for partial seizures.
Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F
Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
